Evidence map›Paper›PMID 42563795›Full record

ArticleAnnals of the Child Neurology Society2025

Advancing FIRES Treatment: The Potential of Intrathecal Dexamethasone.

Carol Park, Douglas R Nordli, Mohamed Taha, Henry David, Shawn Kacker, Tareq Kass-Hout, Sonam Thind, Aurelie Hanin, Sana Said, Hiba A Haider and 1 more

Erratum issuedAbstract read
In one paragraph

Article in Annals of the Child Neurology Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Carol ParkDepartment of Pediatric Neurology, Comer Children's Hospital University of Chicago Chicago Illinois USA.
Douglas R NordliDepartment of Pediatric Neurology, Comer Children's Hospital University of Chicago Chicago Illinois USA.
Mohamed TahaDepartment of Pediatric Neurology, Comer Children's Hospital University of Chicago Chicago Illinois USA.
Henry DavidDepartment of Pediatric Neurology, Comer Children's Hospital University of Chicago Chicago Illinois USA.
Shawn KackerAdvocate Children's Medical Group Park Ridge Illinois USA.
Tareq Kass-HoutDepartment of Neurology University of Chicago Chicago Illinois USA.
Sonam ThindDepartment of Neurology University of Chicago Chicago Illinois USA.
Aurelie HaninDepartment of Neurology, Comprehensive Epilepsy Center Yale University School of Medicine New Haven Connecticut USA.
Sana SaidDepartment of Pharmacy University of Chicago Chicago Illinois USA.
Hiba A HaiderDepartment of Neurology University of Chicago Chicago Illinois USA.
Douglas R NordliDepartment of Pediatric Neurology, Comer Children's Hospital University of Chicago Chicago Illinois USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Febrile infection-related epilepsy syndrome (FIRES) is a rare, devastating epilepsy syndrome characterized by refractory status epilepticus following a febrile illness. Patient Description: We describe a 12-year-old girl with FIRES who exhibited a remarkable clinical and electrographic response to intrathecal dexamethasone (IT-DEX) after failing multiple antiseizure and immunomodulatory therapies. Despite persistent neuroinflammation, IT-DEX led to rapid seizure control and significant neurological recovery. Conclusion: This report supports IT-DEX as a promising intervention in FIRES and underscores the need for further research into its mechanisms and long-term efficacy.

Indexed as

FIRESNORSEstatus epilepticus

Identifiers

PMID42563795
PMCPMC13359124

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.